You are viewing the site in preview mode

Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection

Fig. 4

Receiver operator curve analysis of 19 cases and 41 controls by multivariate logistic regression of individual or combined peptides. Model 1 (a) includes peptides LGGSAVISLEGKPL (CFL1), HTFMGVVSLGSPSGEVSHPR (AHSG), and SPFSVAVSPSLDLSK (FLNA). Model 2 (b) includes peptides LVVLGSGGVGK (RAP1A), VYLFLQPR (ITGA2B), ANLPQSFQVDTSK (FLNA), and LAQAAQSSVATITR (TLN1)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us